Aerovate Therapeutics, Inc.·4

Jan 24, 6:00 PM ET

Pigot Timothy 4

4 · Aerovate Therapeutics, Inc. · Filed Jan 24, 2024

Insider Transaction Report

Form 4
Period: 2024-01-22
Pigot Timothy
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-22+66,58666,586 total
    Exercise: $20.00Exp: 2034-01-21Common Stock (66,586 underlying)
Holdings
  • Common Stock

    1,291
Footnotes (2)
  • [F1]Includes 1,291 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
  • [F2]This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024.

Documents

1 file
  • 4
    form4-01242024_060110.xmlPrimary